Sakina J. Rizvi
University of Toronto
80 Papers
169 Citations
Sakina J. Rizvi is an academic researcher from University of Toronto. The author has contributed to research in topics: Major depressive disorder & Medicine. The author has an hindex of 22, co-authored 55 publications. Previous affiliations of Sakina J. Rizvi include St. Michael's GAA, Sligo & University Health Network.
Chat about Author
Papers
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.
Sidney H. Kennedy,Peter Giacobbe,Sakina J. Rizvi,Franca M. Placenza,Yasunori Nishikawa,Helen S. Mayberg,Andres M. Lozano +6 more
TL;DR: Deep brain stimulation remains a safe and effective treatment for treatment-resistant depression and functional impairment in the areas of physical health and social functioning progressively improved up to the last follow-up visit.
470
Assessing anhedonia in depression: Potentials and pitfalls.
TL;DR: This review will assess the current methodology to measure anhedonia, with a focus on scales and behavioural tasks in humans.
439
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression
Andres M. Lozano,Peter Giacobbe,Clement Hamani,Sakina J. Rizvi,Sidney H. Kennedy,Theodore Kolivakis,Guy Debonnel,Abbas F Sadikot,Raymond W. Lam,Andrew K. Howard,Magda Ilcewicz-Klimek,Christopher R. Honey,Helen S. Mayberg +12 more
TL;DR: Findings from this study corroborate the results of previous reports showing that outcome of SCG DBS may be replicated across centers and are associated with amelioration in disease severity in patients who responded to surgery.
350
Sexual dysfunction, depression, and the impact of antidepressants.
TL;DR: The availability of an antidepressant that does not cause or exacerbate sexual dysfunction represents an advance in pharmacotherapy for mood disorders and should reduce treatment noncompliance and decrease the need for switching antidepressants or adding antidotes.
325
Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression.
Sakina J. Rizvi,Sakina J. Rizvi,Lena C. Quilty,Lena C. Quilty,Beth Sproule,Beth Sproule,Anna Cyriac,R. Michael Bagby,Sidney H. Kennedy,Sidney H. Kennedy,Sidney H. Kennedy +10 more
TL;DR: The Dimensional Anhedonia Rating Scale (DARS) was developed and validated, a dynamic scale that measures desire, motivation, effort and consummatory pleasure across hedonic domains and showed additional utility over the Snaith-Hamilton Pleasure Scale in predicting reward function and distinguishing MDD subgroups.
194